Replies to post #153148 on Biotech Values

[dav1234]

Pfizer (PFE) completes the acquisition of NextWave Pharmaceuticals in deal worth an initial $255M plus milestone amounts of up to $425M. With the purchase, Pfizer gains access to Quillivant XR, an FDA-approved treatment for attention deficit hyperactivity disorder (ADHD